Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer

被引：0
|
作者：
Kelly, R. [1 ]
Wong, S. S. L. [2 ]
Shapiro, J. [3 ]
Weickhardt, A. J. [4 ]
Parente, P. [5 ]
Azad, A. [6 ]
Uccellini, A. [7 ]
Torres, J. [8 ]
Parnis, F. [9 ]
Kwan, E. [10 ]
Brown, S. [11 ]
Steer, C. [12 ]
Warren, M. [13 ]
Gibbs, P. [14 ]
Anton, A. [1 ]
Tran, B. [1 ]
机构：
[1] Walter Eliza Hall Inst Med Res, Clin Data Clin Trials & Biomarkers, Parkville, Vic, Australia
[2] Sunshine Hosp Western Hlth, Med Affairs Dept, St Albans, Vic, Australia
[3] Alfred Hosp, Med Oncol, Melbourne, Vic, Australia
[4] Olivia Newton John Canc Wellness & Res Ctr, Dept Med Oncol, Heidelberg, Vic, Australia
[5] Box Hill Hosp, Eastern Hlth, Dept Med Oncol, Bldg B, Box Hill, Vic, Australia
[6] Peter MacCallum Canc Ctr, Dept Oncol, Melbourne, Vic, Australia
[7] Austin Hosp, Austin Hlth, Med Oncol, Heidelberg, Vic, Australia
[8] Goulburn Valley Hlth, Dept Med Oncol, Shepparton, Vic, Australia
[9] Adelaide Canc Ctr, Dept Med Oncol, Adelaide, SA, Australia
[10] Monash Canc Ctr, Monash Hlth, Med Oncol, Bentleigh East, Vic, Australia
[11] Ballarat Hlth Serv, Med Oncol, Ballarat Base Hosp, Ballarat, Vic, Australia
[12] Border Med Oncol, Dept Med Oncol, East Albury, Vic, Australia
[13] Bendigo Hlth, Med Oncol, Bendigo, Vic, Australia
[14] WEHI Walter & Eliza Hall Inst Med Res, Dept Oncol, Parkville, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.202
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
165P
引用
收藏
页码：S1498 / S1499
页数：2
相关论文
共 50 条
  • [21] Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice
    Park, Kwonoh
    Kim, Jin Young
    Park, Inkeun
    Shin, Seong Hoon
    Lee, Hyo Jin
    Lee, Jae Lyun
    YONSEI MEDICAL JOURNAL, 2023, 64 (02) : 86 - 93
  • [22] The optimal upfront therapy in metastatic hormone-sensitive prostate cancer: A network meta-analysis
    Mutlu, Hasan
    Bozcuk, Hakan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 394 - 402
  • [23] Efficacy and tolerability of docetaxel chemotherapy in 'real-world' patients with metastatic hormone-sensitive prostate cancer (mHSPC)
    Maw, May Tun Hla
    Malik, Laeeq
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 127 - 127
  • [24] Triple therapy in metastatic hormone-sensitive prostate cancer
    Tsaur, Igor
    Mirvald, Cristian
    Surcel, Cristian
    CURRENT OPINION IN UROLOGY, 2023, 33 (06) : 452 - 457
  • [25] Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
    Isaksson, Jenny
    Green, Henrik
    Papantoniou, Dimitrios
    Pettersson, Linn
    Anden, Mats
    Rosell, Johan
    Avall-Lundqvist, Elisabeth
    Elander, Nils Oskar
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 1009 - 1022
  • [26] Systemic therapy in metastatic hormone-sensitive prostate cancer
    McDonald, Jodie
    O'Brien, Jonathan
    Kostos, Louise
    Lawrentschuk, Nathan
    Azad, Arun A.
    Murphy, Declan
    Chen, Kenneth
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (04) : 234 - 239
  • [27] COMPARISON OF UPFRONT ARAT THERAPY AND CAB THERAPY FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A RETROSPECTIVE MULTICENTER STUDY
    Shiraishi, Yusuke
    Tobe, Taisuke
    Ueki, Hideto
    Suzuki, Kotaro
    Hara, Takuto
    Terakawa, Tomoaki
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1003 - E1004
  • [28] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64
  • [29] Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Hindie, Elif
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3873 - 3875
  • [30] Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database
    Eule, Corbin J.
    Kuna, Elizabeth Molina
    Robin, Tyler P.
    Gershman, Boris
    Flaig, Thomas W.
    Kim, Simon P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 447e17 - 447e24
12345